FARALLON CAPITAL MANAGEMENT LLC Alnylam Pharmaceuticals, Inc. Transaction History

FARALLON CAPITAL MANAGEMENT LLC portfolio value:

$85.76M
portfolio value

FARALLON CAPITAL MANAGEMENT LLC quarter portfolio value change:

+37.24%
quarter

Alnylam Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -45.62% -359.45K shares -29.15M $200.16 428.45K
Q2 2022 share Decrease -23.05% -235.96K shares -52.27M $145.85 787.91K
Q1 2022 share Decrease -13.96% -166.15K shares -34.61M $163.29 1.02M
Q4 2021 share Increase +46.14% 375.72K shares 48.05M $171.03 1.19M
Q3 2021 share Decrease -14.28% -135.69K shares -7.29M $188.81 814.30K
Q2 2021 share Increase +35.71% 250K shares 62.21M $169.52 950K
Q1 2021 share Increase +100.00% 350K shares 53.34M $141.19 700K
Q4 2020 share Decrease -70.83% -850K shares -129.23M $129.97 350K
Q3 2020 share Increase +14.29% 150K shares 19.20M $145.6 1.2M
Q2 2020 share Decrease -30.00% -450K shares -7.75M $148.11 1.05M
Q1 2020 share Increase +3.45% 50K shares -3.72M $108.85 1.5M
Q4 2019 share Decrease -3.33% -50K shares 46.36M $115.17 1.45M
Q3 2019 share Increase +36.36% 400K shares 40.81M $80.42 1.5M
Q2 2019 share Increase +120.00% 600K shares 33.09M $72.56 1.1M
Q1 2019 share Decrease -9.09% -50K shares 6.62M $93.45 500K
Q4 2018 share Increase +98.88% 273.44K shares 15.89M $72.91 550K
Q3 2018 share Decrease -33.36% -138.44K shares -16.66M $87.52 276.55K
Q2 2018 share Increase +12.16% 45K shares -3.19M $98.49 415K
Q1 2018 share Increase 0.00% 370K shares 44.06M $119.1 370K
Q3 2017 share Decrease -100.00% -200K shares -15.95M $117.49 0
Q2 2017 share Increase 0.00% 200K shares 15.95M $79.76 200K